AEON AEON Biopharma Inc. - Ordinary Shares - Class A

$AEON i have not been following too closely but i do like there regulatory guy. very rare to find a reg guy that worked at the FDA. if this thing tanks again its almost worth buying in

$AEON Well, if shareholders can maintain .32 on Nov. 16th capital structure improves dramatically with $15M injection🧐

$AEON sold long ago and back after a leave of absence. seems like an RS is a ways off. could be good to get back in

$AEON i’m right there with you TW I’m very bullish on this stock, but the numbers are the numbers they’re gonna have to raise money before they start playing these FDA games. I think the market knows this and the market also possibly sees a reverse split.

$AEON see no reason for strength these last several days …. NO REASONS WHATSOEVER…. grab rug here …. PULL!

$AEON Who is lobbying this ticker? What firm is playing footsies? Peptides before this?!!! WTF. GTA6 will drop before we get something from this.

$AEON use retail money to try and produce something... its not working and everyone has to be paid still. The coffers are empty, sell the story? Who will buy in who wont. When retail has bought up all the shares and the company still reports empty coffers, lets vote on a reverse split, less shares, price matches the losses already, everyone sitting in hope. Then down it goes some more., sell the story, try to get new investment, still no product, another reverse split. Dont waste your money on if buts and maybes. This stock cant hold above 30 cents, so whats the next story???

$AEON i always find it fascinating how few take some time to research. it looks like they are voting on an RS

$AEON Disappointed doesn't begin to describe my thoughts on this stock. The company likely just saved $30M and almost a year by not needing a comparative study. The molecule is so well studied that they can innundate the FDA with data. Approval seems highly likely and this will take a ton of share due to better economics. I was so excited to buy it here on Wednesday. Thought it would never trade here again. I guess the moral to the story is that all micro-cap biotechs are trading vehicles not investments?!? Dang...